Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Dopamine Receptor D1 Blocking Peptide (AC1327)
Cat.#: ACPP-1327
Specifications
Despition Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1399 Human LGALS7 Protein (AC1399) 2 µg inquiry ACPP-1649 Human EFNA5 Protein (AC1649) 2 µg inquiry ACPP-1059 Recombinant Human ALK Protein (Fc Tag) (AC1059) 50 µg inquiry ACPP-1056 Recombinant Human CX3CR1 Protein (Fc Tag) (AC1056) 50 µg inquiry ACPP-1306 FGFR2 Blocking Peptide (AC1306) 250 µg inquiry ACPP-1366 Dopamine D5 Receptor Blocking Peptide (AC1366) 250 µg inquiry ACPP-1480 Human FKBP1B Protein (AC1480) 5 µg inquiry ACPP-1741 Human NDRG1 Protein (AC1741) 10 µg inquiry ACPP-1783 Human SAT2 Protein (AC1783) 5 µg inquiry ACPP-1653 Human CRYM Protein (AC1653) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket